Chicago Capital’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-464,694
Closed -$9.33M 243
2020
Q4
$9.33M Sell
464,694
-366,357
-44% -$7.67M 0.42% 50
2020
Q3
$20.3M Buy
831,051
+7,126
+0.9% +$166K 1.04% 38
2020
Q2
$19.6M Buy
823,925
+18,363
+2% +$426K 1.13% 37
2020
Q1
$13.9M Sell
805,562
-551
-0.1% -$10.1K 1.12% 34
2019
Q4
$14.2M Buy
806,113
+4,553
+0.6% +$77.2K 0.87% 43
2019
Q3
$14.2M Sell
801,560
-1,424
-0.2% -$28.8K 0.95% 44
2019
Q2
$17.2M Buy
802,984
+13,850
+2% +$290K 1.1% 40
2019
Q1
$18.8M Buy
789,134
+46,997
+6% +$1.07M 1.28% 37
2018
Q4
$14.6M Sell
742,137
-13,445
-2% -$240K 1.19% 41
2018
Q3
$13.4M Buy
755,582
+175,560
+30% +$3.42M 0.93% 44
2018
Q2
$12.5M Buy
580,022
+204,351
+54% +$4.23M 1.01% 43
2018
Q1
$8.32M Buy
+375,671
New +$10.4M 1.11% 40

Other funds holding EXEL

Chicago Capital's EXEL Position: Q1 2021 in Review

Chicago Capital sold out of Exelixis (EXEL) in Q1 2021, closing a stake of 464,694 shares — an estimated $9.33M sold.

Chicago Capital first reported a position in EXEL in Q1 2018 and held it in 12 quarters. The position peaked at $20.3M in Q3 2020. 348 funds tracked by Wall St. Rank hold EXEL as of Q1 2021.

  • Chicago Capital reported no remaining Exelixis position as of Q1 2021 after selling out during the quarter.
  • Chicago Capital sold 464,694 Exelixis shares in Q1 2021, an estimated $9.33M.
  • Chicago Capital first reported a position in Exelixis in Q1 2018 and held it in 12 quarters.
  • Chicago Capital's Exelixis position peaked at $20.3M in Q3 2020.
  • 348 funds tracked by Wall St. Rank held Exelixis as of Q1 2021.

Based on Chicago Capital's 13F filing for Q1 2021, filed 13 Apr 2021.